36 related articles for article (PubMed ID: 7749580)
1. Preliminary X-ray crystallographic studies of BthTX-II, a myotoxic Asp49-phospholipase A2 with low catalytic activity from Bothrops jararacussu venom.
Corrêa LC; Marchi-Salvador DP; Cintra AC; Soares AM; Fontes MR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Aug; 62(Pt 8):765-7. PubMed ID: 16880551
[TBL] [Abstract][Full Text] [Related]
2. Crystallization and preliminary X-ray diffraction analysis of myotoxin I, a Lys49-phospholipase A2 from Bothrops moojeni.
Marchi-Salvador DP; Silveira LB; Soares AM; Fontes MR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Oct; 61(Pt 10):882-4. PubMed ID: 16511185
[TBL] [Abstract][Full Text] [Related]
3. Molecular Architecture of the Antiophidic Protein DM64 and its Binding Specificity to Myotoxin II From
Soares BS; Rocha SLG; Bastos VA; Lima DB; Carvalho PC; Gozzo FC; Demeler B; Williams TL; Arnold J; Henrickson A; Jørgensen TJD; Souza TACB; Perales J; Valente RH; Lomonte B; Gomes-Neto F; Neves-Ferreira AGC
Front Mol Biosci; 2021; 8():787368. PubMed ID: 35155563
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle fiber hypercontraction induced by Bothrops asper myotoxic phospholipases A
López-Dávila AJ; Weber N; Nayak A; Fritz L; Moustafa KR; Gand LV; Wehry E; Kraft T; Thum T; Fernández J; Gutiérrez JM; Lomonte B
Pflugers Arch; 2023 Oct; 475(10):1193-1202. PubMed ID: 37474774
[TBL] [Abstract][Full Text] [Related]
5. Can Inhibitors of Snake Venom Phospholipases A₂ Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study.
Sales TA; Marcussi S; da Cunha EFF; Kuca K; Ramalho TC
Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29068410
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper.
Sørensen CV; Fernández J; Adams AC; Wildenauer HHK; Schoffelen S; Ledsgaard L; Pucca MB; Fiebig M; Cerni FA; Tulika T; Voldborg BG; Karatt-Vellatt A; Morth JP; Ljungars A; Grav LM; Lomonte B; Laustsen AH
Nat Commun; 2024 Jan; 15(1):173. PubMed ID: 38228619
[TBL] [Abstract][Full Text] [Related]
7. Chemical modifications of PhTX-I myotoxin from Porthidium hyoprora snake venom: effects on structural, enzymatic, and pharmacological properties.
Huancahuire-Vega S; Corrêa DH; Hollanda LM; Lancellotti M; Ramos CH; Ponce-Soto LA; Marangoni S
Biomed Res Int; 2013; 2013():103494. PubMed ID: 23484072
[TBL] [Abstract][Full Text] [Related]
8. Alpha-type phospholipase A
Santos-Filho NA; Santos CT
J Venom Anim Toxins Incl Trop Dis; 2017; 23():19. PubMed ID: 28344595
[TBL] [Abstract][Full Text] [Related]
9. Purification, Characterization and Evaluation of the Antitumoral Activity of a Phospholipase A2 from the Snake
Frihling BEF; Boleti APA; de Oliveira CFR; Sanches SC; Cardoso PHO; Verbisck N; Macedo MLR; Rita PHS; Carvalho CME; Migliolo L
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745643
[TBL] [Abstract][Full Text] [Related]
10. In vitro antiplasmodial activity of phospholipases A2 and a phospholipase homologue isolated from the venom of the snake Bothrops asper.
Castillo JC; Vargas LJ; Segura C; Gutiérrez JM; Pérez JC
Toxins (Basel); 2012 Dec; 4(12):1500-16. PubMed ID: 23242318
[TBL] [Abstract][Full Text] [Related]
11. Secreted phospholipases A(2), a new class of HIV inhibitors that block virus entry into host cells.
Fenard D; Lambeau G; Valentin E; Lefebvre JC; Lazdunski M; Doglio A
J Clin Invest; 1999 Sep; 104(5):611-8. PubMed ID: 10487775
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper.
Lizano S; Lomonte B; Fox JW; Gutiérrez JM
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):853-9. PubMed ID: 9307037
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of myotoxin II from Atropoides (Bothrops) nummifer snake venom, a new Lys49 phospholipase A2 homologue.
Angulo Y; Olamendi-Portugal T; Possani LD; Lomonte B
Int J Biochem Cell Biol; 2000 Jan; 32(1):63-71. PubMed ID: 10661894
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization and role in toxic activities of region 115-129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom.
Calderón L; Lomonte B
Arch Biochem Biophys; 1998 Oct; 358(2):343-50. PubMed ID: 9784249
[TBL] [Abstract][Full Text] [Related]
15. Broad cytolytic specificity of myotoxin II, a lysine-49 phospholipase A2 of Bothrops asper snake venom.
Lomonte B; Tarkowski A; Hanson LA
Toxicon; 1994 Nov; 32(11):1359-69. PubMed ID: 7886694
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase A2 myotoxins from Bothrops snake venoms.
Gutiérrez JM; Lomonte B
Toxicon; 1995 Nov; 33(11):1405-24. PubMed ID: 8744981
[TBL] [Abstract][Full Text] [Related]
17. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action.
Lomonte B; Angulo Y; Calderón L
Toxicon; 2003 Dec; 42(8):885-901. PubMed ID: 15019489
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of myotoxin IV, a phospholipase A2 variant, from Bothrops asper snake venom.
Díaz C; Lomonte B; Zamudio F; Gutiérrez JM
Nat Toxins; 1995; 3(1):26-31. PubMed ID: 7749580
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
